![]() | |
Names | |
---|---|
IUPAC name BenzylN-{(2S)-2-[([2-(acetylsulfanyl)ethoxy]{[(R)-amino(phenyl)methyl]phosphonoyl})methyl]-3-([1,1′-biphenyl]-4-yl)propanoyl}-L-alaninate | |
Systematic IUPAC name Benzyl (9S,12S)-7-[(R)-amino(phenyl)methyl]-9-[([1,1′-biphenyl]-4-yl)methyl]-12-methyl-2,7,10-trioxo-6-oxa-3-thia-11-aza-7λ5-phosphatridecan-13-oate | |
Other names RB3007, LS-15768 | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
| |
| |
Properties | |
C37H41N2O6PS | |
Molar mass | 672.78 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). |
RB-3007 is an orally active analogue ofRB-101. It acts as anenkephalinase inhibitor, which is used in scientific research.[1][2]